Cardiovascular surgery, Digestive surgery
Conditions
Interventions
Use of 1.5% Olanexidine gluconate for surgical site before surgery
Use of 1.0% Chlorhexidine gluconate for surgical site before surgery
Sponsors
Iwaki city medical center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients that satisfy all of the below requirements. 1)Surgery for cardiovascular surgery with sternotomy, or gastrointestinal surgery with laparotomy additionally wound classification class II or less. 2)The age is older than 18 years of age. 3)Having provided voluntary written consent for participation in this study.
Exclusion criteria
Exclusion criteria: Patients with any of the following cases are excluded. 1)Patients contraindicated for Olanexidine glucose or Chlorhexidine Gluconate 2)Follow- up failure due to pass-away or other reasons. 3)In case of urgent operation 4)Patients judged by investigators ineligible due to seriousness of patients condition.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative 30-day surgical site infection (SSI) rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative 30-day superficial incisional SSI rate, deep incisional SSI rate, organ/space SSI rate, rate of positive bacterial wound culture, and their strains, and toxicity and allergies events rate | — |
Countries
Japan
Contacts
Public ContactYoshiki Endo
Iwaki city medical center Department of cardiovascular surgery
Outcome results
None listed